share_log

Vivos Therapeutics | 8-K: Current report

Vivos Therapeutics | 8-K: Current report

Vivos Therapeutics | 8-K:重大事件
美股SEC公告 ·  2024/09/18 04:11

Moomoo AI 已提取核心信息

Vivos Therapeutics has scheduled its 2024 Annual Meeting of Stockholders for November 26, 2024, with October 4, 2024, set as the record date for determining voting eligibility. The company will disclose the meeting's time and location in its upcoming definitive proxy statement.Due to the meeting date being more than 30 days after the 2023 Annual Meeting anniversary, the company has established new deadlines for stockholder proposals. All stockholder proposals, whether under Rule 14a-8 or for director nominations, must be submitted by September 27, 2024. This deadline applies to proposals intended for inclusion in proxy materials and those to be presented directly at the meeting.
Vivos Therapeutics has scheduled its 2024 Annual Meeting of Stockholders for November 26, 2024, with October 4, 2024, set as the record date for determining voting eligibility. The company will disclose the meeting's time and location in its upcoming definitive proxy statement.Due to the meeting date being more than 30 days after the 2023 Annual Meeting anniversary, the company has established new deadlines for stockholder proposals. All stockholder proposals, whether under Rule 14a-8 or for director nominations, must be submitted by September 27, 2024. This deadline applies to proposals intended for inclusion in proxy materials and those to be presented directly at the meeting.
Vivos Therapeutics将于2024年11月26日召开2024年股东年会,登记日期定为2024年10月4日,以确定投票资格。公司将在即将发布的最终委托书声明中披露会议的时间和地点。由于会议日期距离2023年股东年会周年超过30天,公司设定了新的股东提案截止日期。所有股东提案,无论是根据14a-8规则还是董事提名,必须在2024年9月27日之前提交。此截止日期适用于希望包含在委托书材料中的提案,以及将在会议上直接提出的提案。
Vivos Therapeutics将于2024年11月26日召开2024年股东年会,登记日期定为2024年10月4日,以确定投票资格。公司将在即将发布的最终委托书声明中披露会议的时间和地点。由于会议日期距离2023年股东年会周年超过30天,公司设定了新的股东提案截止日期。所有股东提案,无论是根据14a-8规则还是董事提名,必须在2024年9月27日之前提交。此截止日期适用于希望包含在委托书材料中的提案,以及将在会议上直接提出的提案。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息